SCYNEXIS, Inc. Income (Loss) from Continuing Operations, Per Diluted Share
SCYNEXIS, Inc. (SCYX) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$1.58 per share for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2017-03-13
- SCYNEXIS, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2015-09-30 was -$0.54.
- SCYNEXIS, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2015-06-30 was -$0.53.
- SCYNEXIS, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2015-03-31 was -$0.70.
- SCYNEXIS, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2014-09-30 was -$0.50.
- SCYNEXIS, Inc. income (loss) from continuing operations, per diluted share for fiscal 2016 was -$1.58.
- SCYNEXIS, Inc. income (loss) from continuing operations, per diluted share for fiscal 2015 was -$2.33.
- SCYNEXIS, Inc. income (loss) from continuing operations, per diluted share for fiscal 2014 was -$2.92.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$1.58 10-K · filed 2017-03-13 | |||
| 2015-12-31 | -$2.33 10-K · filed 2017-03-13 | |||
| 2015-09-30 | -$0.54 10-Q · filed 2015-11-13 | -$1.72 10-Q · filed 2015-11-13 | ||
| 2015-06-30 | -$0.53 10-Q · filed 2015-08-19 | -$1.20 10-Q · filed 2015-08-19 | ||
| 2015-03-31 | -$0.70 8-K · filed 2015-10-30 | |||
| 2014-12-31 | -$2.92 10-K · filed 2017-03-13 | |||
| 2014-09-30 | -$0.50 10-Q · filed 2015-11-13 | -$2.80 10-Q · filed 2015-11-13 | ||
| 2014-06-30 | -$1.08 10-Q · filed 2015-08-19 | -$3.49 10-Q · filed 2015-08-19 | ||
| 2014-03-31 | -$7.17 8-K · filed 2015-10-30 | |||
| 2013-12-31 | -$142.06 8-K · filed 2015-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |